JAGUAR HEALTH, INC. Interest on Convertible Debt, Net of Tax
JAGUAR HEALTH, INC. (JAGX) reported Interest on Convertible Debt, Net of Tax of $209.15 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2018-11-19.
Discontinued › Notes
us-gaap:InterestOnConvertibleDebtNetOfTax · last filed 2018-11-19
- JAGUAR HEALTH, INC. interest on convertible debt, net of tax for the quarter ending 2017-09-30 was $209.15K.
| Period end | Interest on Convertible Debt, Net of Tax 3 month |
|---|---|
| 2017-09-30 | $209.15K 10-Q · filed 2018-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |